melatonin has been researched along with Atheroma in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Melatonin (MLT) is an endogenous indole compound with numerous biological activities that has been associated with atherosclerosis (AS)." | 7.81 | Melatonin alleviates myosin light chain kinase expression and activity via the mitogen-activated protein kinase pathway during atherosclerosis in rabbits. ( Cheng, X; Wan, Y; Wang, Y; Xu, Y; Zhou, Q; Zhu, H, 2015) |
| "Melatonin (MLT) is an endogenous indole compound with numerous biological activities that has been associated with atherosclerosis (AS)." | 3.81 | Melatonin alleviates myosin light chain kinase expression and activity via the mitogen-activated protein kinase pathway during atherosclerosis in rabbits. ( Cheng, X; Wan, Y; Wang, Y; Xu, Y; Zhou, Q; Zhu, H, 2015) |
| "Melatonin has atheroprotective effects by acting on different pathogenic signaling processes; these result from its direct free radical scavenger activity, its indirect antioxidant properties and its anti-inflammatory actions." | 2.50 | Melatonin and its atheroprotective effects: a review. ( Favero, G; Reiter, RJ; Rezzani, R; Rodella, LF, 2014) |
| "High-dose melatonin enhanced atherosclerotic plaque stability in ApoE mice in vivo by inducing the expression of P4Hα1, which was reversed by MTM." | 1.51 | Melatonin enhances atherosclerotic plaque stability by inducing prolyl-4-hydroxylase α1 expression. ( Chen, W; Jiang, X; Li, H; Li, J; Liu, S; Liu, Y; Yang, J; Zhang, C; Zhang, W, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Maity, J | 3 |
| Dey, T | 3 |
| Banerjee, A | 3 |
| Chattopadhyay, A | 3 |
| Das, AR | 3 |
| Bandyopadhyay, D | 3 |
| Hu, ZP | 1 |
| Fang, XL | 1 |
| Sheng, B | 1 |
| Guo, Y | 1 |
| Yu, YQ | 1 |
| Ma, S | 1 |
| Chen, J | 1 |
| Feng, J | 1 |
| Zhang, R | 1 |
| Fan, M | 1 |
| Han, D | 1 |
| Li, X | 1 |
| Li, C | 1 |
| Ren, J | 1 |
| Wang, Y | 2 |
| Cao, F | 1 |
| Li, H | 1 |
| Li, J | 1 |
| Jiang, X | 1 |
| Liu, S | 1 |
| Liu, Y | 1 |
| Chen, W | 1 |
| Yang, J | 1 |
| Zhang, C | 1 |
| Zhang, W | 1 |
| Ding, S | 1 |
| Lin, N | 1 |
| Sheng, X | 1 |
| Zhao, Y | 1 |
| Su, Y | 1 |
| Xu, L | 1 |
| Tong, R | 1 |
| Yan, Y | 1 |
| Fu, Y | 1 |
| He, J | 1 |
| Gao, Y | 1 |
| Yuan, A | 1 |
| Ye, L | 1 |
| Reiter, RJ | 2 |
| Pu, J | 1 |
| Favero, G | 1 |
| Rodella, LF | 1 |
| Rezzani, R | 1 |
| Cheng, X | 1 |
| Wan, Y | 1 |
| Xu, Y | 1 |
| Zhou, Q | 1 |
| Zhu, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Intervention Effect Of Melatonin On The Risk Of Cardiovascular Events And Malignant Tumors In The Elderly: A Prospective, Randomized Parallel Controlled Study Based On Large Cohorts[NCT04631341] | 10,000 participants (Anticipated) | Interventional | 2021-01-01 | Not yet recruiting | |||
| Melatonin and Essential Arterial Hypertension[NCT05257291] | Phase 2 | 23 participants (Actual) | Interventional | 2018-02-02 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for melatonin and Atheroma
| Article | Year |
|---|---|
Melatonin ameliorates myocardial infarction in obese diabetic individuals: The possible involvement of macrophage apoptotic factors.
Topics: Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cholesterol; Diabetes Mellitus, Type 2; Humans; M | 2023 |
Melatonin ameliorates myocardial infarction in obese diabetic individuals: The possible involvement of macrophage apoptotic factors.
Topics: Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cholesterol; Diabetes Mellitus, Type 2; Humans; M | 2023 |
Melatonin ameliorates myocardial infarction in obese diabetic individuals: The possible involvement of macrophage apoptotic factors.
Topics: Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cholesterol; Diabetes Mellitus, Type 2; Humans; M | 2023 |
Melatonin ameliorates myocardial infarction in obese diabetic individuals: The possible involvement of macrophage apoptotic factors.
Topics: Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cholesterol; Diabetes Mellitus, Type 2; Humans; M | 2023 |
Melatonin and its atheroprotective effects: a review.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Atherosclerosis; Gene Expression Regulation; Humans | 2014 |
5 other studies available for melatonin and Atheroma
| Article | Year |
|---|---|
Melatonin inhibits macrophage infiltration and promotes plaque stabilization by upregulating anti-inflammatory HGF/c-Met system in the atherosclerotic rabbit: USPIO-enhanced MRI assessment.
Topics: Animals; Anti-Inflammatory Agents; Aorta, Abdominal; Aortic Diseases; Atherosclerosis; Contrast Medi | 2020 |
Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition.
Topics: Animals; Atherosclerosis; Disease Progression; Forkhead Box Protein O3; Free Radical Scavengers; Inf | 2018 |
Melatonin enhances atherosclerotic plaque stability by inducing prolyl-4-hydroxylase α1 expression.
Topics: Animals; Apolipoproteins E; Cell Line; Central Nervous System Depressants; Chromones; Enzyme Inhibit | 2019 |
Melatonin stabilizes rupture-prone vulnerable plaques via regulating macrophage polarization in a nuclear circadian receptor RORα-dependent manner.
Topics: Animals; Atherosclerosis; Humans; Macrophages; Male; Melatonin; Mice; Mice, Knockout, ApoE; Nuclear | 2019 |
Melatonin alleviates myosin light chain kinase expression and activity via the mitogen-activated protein kinase pathway during atherosclerosis in rabbits.
Topics: Animals; Aorta; Atherosclerosis; Capillary Permeability; Disease Models, Animal; Extracellular Signa | 2015 |